Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Blueprint Medicines (BPMC – Research Report) yesterday and set a price target of ...
Oppenheimer analyst Matthew Biegler maintained a Buy rating on Arvinas Holding Company (ARVN – Research Report) yesterday and set a price ...
Roche Holding AG Akt 0.65% CHF232.25B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback